Tetracosactide Other names: Tetracosactrin Cosyntropin ACTH test Synacthen test

Chemical formula: C₁₃₆H₂₁₀N₄₀O₃₁S  Molecular mass: 2,933.49 g/mol  PubChem compound: 16133751

Therapeutic indications

Tetracosactide is indicated for:

Indication

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old)

Convulsions of newborn

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adults (18 - 65 years old)

Multiple sclerosis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adults (18 years old or older)

Hypoadrenalism

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL) 2020: CORTROSYN Powder for solution for injection
Summary of Product Characteristics (SPC) 2020: SYNACTHEN DEPOT Suspension for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈